| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.82e-06 | 560 | 10 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 4.03e-06 | 566 | 10 | 5 | GO:0001216 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 9.76e-06 | 1244 | 10 | 6 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.11e-05 | 1271 | 10 | 6 | GO:0000987 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.03e-05 | 1412 | 10 | 6 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.45e-05 | 1459 | 10 | 6 | GO:0000977 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 7.52e-04 | 83 | 10 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 2.33e-03 | 147 | 10 | 2 | GO:0042826 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.98e-03 | 739 | 10 | 3 | GO:0003682 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.06e-02 | 320 | 10 | 2 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.10e-02 | 326 | 10 | 2 | GO:0001217 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 6.23e-07 | 1390 | 10 | 7 | GO:0045944 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 3.44e-06 | 238 | 10 | 4 | GO:0048639 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.38e-05 | 338 | 10 | 4 | GO:0045165 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 1.39e-05 | 339 | 10 | 4 | GO:0045927 | |
| GeneOntologyBiologicalProcess | regulation of growth | 1.61e-05 | 777 | 10 | 5 | GO:0040008 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 3.26e-05 | 421 | 10 | 4 | GO:0048638 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 3.62e-05 | 141 | 10 | 3 | GO:0001952 | |
| GeneOntologyBiologicalProcess | endocrine system development | 5.38e-05 | 161 | 10 | 3 | GO:0035270 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle cell differentiation | 5.81e-05 | 24 | 10 | 2 | GO:0051151 | |
| GeneOntologyBiologicalProcess | atrioventricular valve morphogenesis | 7.94e-05 | 28 | 10 | 2 | GO:0003181 | |
| GeneOntologyBiologicalProcess | gland development | 9.77e-05 | 558 | 10 | 4 | GO:0048732 | |
| GeneOntologyBiologicalProcess | atrioventricular valve development | 1.04e-04 | 32 | 10 | 2 | GO:0003171 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.18e-04 | 210 | 10 | 3 | GO:0007219 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 1.41e-04 | 1220 | 10 | 5 | GO:0051093 | |
| GeneOntologyBiologicalProcess | growth | 1.49e-04 | 1235 | 10 | 5 | GO:0040007 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 1.55e-04 | 39 | 10 | 2 | GO:0003180 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 2.08e-04 | 254 | 10 | 3 | GO:0010810 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 2.10e-04 | 1327 | 10 | 5 | GO:0040012 | |
| GeneOntologyBiologicalProcess | aortic valve development | 2.16e-04 | 46 | 10 | 2 | GO:0003176 | |
| GeneOntologyBiologicalProcess | regulation of transcription regulatory region DNA binding | 2.16e-04 | 46 | 10 | 2 | GO:2000677 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 2.49e-04 | 270 | 10 | 3 | GO:0007160 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 2.56e-04 | 50 | 10 | 2 | GO:1905314 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell differentiation | 2.99e-04 | 54 | 10 | 2 | GO:0051150 | |
| GeneOntologyBiologicalProcess | circulatory system development | 3.10e-04 | 1442 | 10 | 5 | GO:0072359 | |
| GeneOntologyBiologicalProcess | heart development | 3.17e-04 | 757 | 10 | 4 | GO:0007507 | |
| GeneOntologyBiologicalProcess | epithelium development | 3.39e-04 | 1469 | 10 | 5 | GO:0060429 | |
| GeneOntologyBiologicalProcess | endocrine pancreas development | 3.81e-04 | 61 | 10 | 2 | GO:0031018 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 4.07e-04 | 63 | 10 | 2 | GO:0003179 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 5.38e-04 | 870 | 10 | 4 | GO:0030855 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 5.50e-04 | 875 | 10 | 4 | GO:0045596 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 5.92e-04 | 76 | 10 | 2 | GO:0003229 | |
| GeneOntologyBiologicalProcess | heart valve development | 6.23e-04 | 78 | 10 | 2 | GO:0003170 | |
| GeneOntologyBiologicalProcess | developmental growth | 6.41e-04 | 911 | 10 | 4 | GO:0048589 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell differentiation | 7.05e-04 | 83 | 10 | 2 | GO:0051148 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell apoptotic process | 7.22e-04 | 84 | 10 | 2 | GO:0010665 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel endothelial cell migration | 7.39e-04 | 85 | 10 | 2 | GO:0043537 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell apoptotic process | 7.92e-04 | 88 | 10 | 2 | GO:0010662 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell apoptotic process | 8.28e-04 | 90 | 10 | 2 | GO:0010659 | |
| GeneOntologyBiologicalProcess | diencephalon development | 8.28e-04 | 90 | 10 | 2 | GO:0021536 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 8.43e-04 | 410 | 10 | 3 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 8.55e-04 | 412 | 10 | 3 | GO:0090287 | |
| GeneOntologyBiologicalProcess | striated muscle cell apoptotic process | 9.03e-04 | 94 | 10 | 2 | GO:0010658 | |
| GeneOntologyBiologicalProcess | peripheral nervous system development | 9.81e-04 | 98 | 10 | 2 | GO:0007422 | |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 1.00e-03 | 99 | 10 | 2 | GO:0051145 | |
| GeneOntologyBiologicalProcess | pancreas development | 1.06e-03 | 102 | 10 | 2 | GO:0031016 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 1.12e-03 | 105 | 10 | 2 | GO:0048708 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell migration | 1.12e-03 | 105 | 10 | 2 | GO:0010596 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 1.26e-03 | 1090 | 10 | 4 | GO:0022603 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 1.28e-03 | 1095 | 10 | 4 | GO:0060284 | |
| GeneOntologyBiologicalProcess | axis specification | 1.30e-03 | 113 | 10 | 2 | GO:0009798 | |
| GeneOntologyBiologicalProcess | regulation of DNA binding | 1.35e-03 | 115 | 10 | 2 | GO:0051101 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell migration | 1.59e-03 | 125 | 10 | 2 | GO:0010633 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.63e-03 | 515 | 10 | 3 | GO:0050767 | |
| GeneOntologyBiologicalProcess | response to estradiol | 1.66e-03 | 128 | 10 | 2 | GO:0032355 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 1.67e-03 | 519 | 10 | 3 | GO:0001558 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 1.87e-03 | 1211 | 10 | 4 | GO:0030334 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 1.93e-03 | 138 | 10 | 2 | GO:0030512 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell apoptotic process | 2.01e-03 | 141 | 10 | 2 | GO:0010660 | |
| GeneOntologyBiologicalProcess | limbic system development | 2.01e-03 | 141 | 10 | 2 | GO:0021761 | |
| GeneOntologyBiologicalProcess | cerebral cortex development | 2.19e-03 | 147 | 10 | 2 | GO:0021987 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.22e-03 | 1269 | 10 | 4 | GO:0009887 | |
| GeneOntologyBiologicalProcess | muscle cell apoptotic process | 2.28e-03 | 150 | 10 | 2 | GO:0010657 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 2.29e-03 | 1280 | 10 | 4 | GO:2000145 | |
| GeneOntologyCellularComponent | chromatin | 8.73e-07 | 1480 | 10 | 7 | GO:0000785 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.20e-04 | 596 | 10 | 4 | GO:0005667 | |
| MousePheno | abnormal bile duct development | 4.81e-05 | 15 | 10 | 2 | MP:0002929 | |
| MousePheno | postnatal growth retardation | 1.90e-04 | 881 | 10 | 5 | MP:0001732 | |
| MousePheno | abnormal postnatal growth | 2.18e-04 | 907 | 10 | 5 | MP:0001731 | |
| Domain | - | 7.23e-10 | 27 | 10 | 4 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 9.78e-10 | 29 | 10 | 4 | IPR010982 | |
| Domain | Homeobox | 7.08e-08 | 234 | 10 | 5 | PF00046 | |
| Domain | HOMEOBOX_1 | 7.39e-08 | 236 | 10 | 5 | PS00027 | |
| Domain | HOX | 7.55e-08 | 237 | 10 | 5 | SM00389 | |
| Domain | Homeobox_dom | 7.87e-08 | 239 | 10 | 5 | IPR001356 | |
| Domain | HOMEOBOX_2 | 7.87e-08 | 239 | 10 | 5 | PS50071 | |
| Domain | - | 1.83e-07 | 283 | 10 | 5 | 1.10.10.60 | |
| Domain | Homeodomain-like | 4.03e-07 | 332 | 10 | 5 | IPR009057 | |
| Domain | CUT_dom | 5.41e-06 | 7 | 10 | 2 | IPR003350 | |
| Domain | CUT | 5.41e-06 | 7 | 10 | 2 | PF02376 | |
| Domain | CUT | 5.41e-06 | 7 | 10 | 2 | SM01109 | |
| Domain | CUT | 5.41e-06 | 7 | 10 | 2 | PS51042 | |
| Domain | POU_3 | 3.08e-05 | 16 | 10 | 2 | PS51179 | |
| Domain | POU_2 | 3.08e-05 | 16 | 10 | 2 | PS00465 | |
| Domain | Pou | 3.08e-05 | 16 | 10 | 2 | PF00157 | |
| Domain | POU_dom | 3.08e-05 | 16 | 10 | 2 | IPR000327 | |
| Domain | POU_1 | 3.08e-05 | 16 | 10 | 2 | PS00035 | |
| Domain | POU | 3.08e-05 | 16 | 10 | 2 | SM00352 | |
| Domain | POU | 3.49e-05 | 17 | 10 | 2 | IPR013847 | |
| Domain | Homeobox_CS | 1.11e-04 | 186 | 10 | 3 | IPR017970 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 4.20e-04 | 64 | 7 | 2 | M200 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 5.46e-04 | 73 | 7 | 2 | M39401 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 9.62e-04 | 97 | 7 | 2 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.04e-03 | 101 | 7 | 2 | M39448 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.40e-03 | 154 | 7 | 2 | M39739 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 2.56e-03 | 159 | 7 | 2 | M39373 | |
| Pubmed | Onecut 1 and Onecut 2 are potential regulators of mouse retinal development. | 9.58e-10 | 8 | 10 | 3 | 21830221 | |
| Pubmed | 1.39e-08 | 18 | 10 | 3 | 25794677 | ||
| Pubmed | Onecut1 is essential for horizontal cell genesis and retinal integrity. | 2.27e-08 | 21 | 10 | 3 | 23926259 | |
| Pubmed | Relief of hypoxia by angiogenesis promotes neural stem cell differentiation by targeting glycolysis. | 4.43e-08 | 26 | 10 | 3 | 26856890 | |
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 4.43e-08 | 26 | 10 | 3 | 19369401 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 5.98e-08 | 908 | 10 | 6 | 19274049 | |
| Pubmed | Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. | 6.23e-08 | 29 | 10 | 3 | 18038450 | |
| Pubmed | Dose-dependent regulation of horizontal cell fate by Onecut family of transcription factors. | 7.44e-08 | 2 | 10 | 2 | 32790713 | |
| Pubmed | 9.30e-08 | 33 | 10 | 3 | 19336002 | ||
| Pubmed | Onecut1 and Onecut2 redundantly regulate early retinal cell fates during development. | 2.10e-07 | 43 | 10 | 3 | 25228773 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 2.17e-07 | 544 | 10 | 5 | 28473536 | |
| Pubmed | OC-3, a novel mammalian member of the ONECUT class of transcription factors. | 2.23e-07 | 3 | 10 | 2 | 11944891 | |
| Pubmed | ONECUT transcription factors induce neuronal characteristics and remodel chromatin accessibility. | 2.23e-07 | 3 | 10 | 2 | 31049588 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 9915796 | ||
| Pubmed | 3.98e-07 | 53 | 10 | 3 | 27210758 | ||
| Pubmed | Cloning and embryonic expression pattern of the mouse Onecut transcription factor OC-2. | 4.46e-07 | 4 | 10 | 2 | 12971999 | |
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 15159395 | ||
| Pubmed | MiR-495 and miR-218 regulate the expression of the Onecut transcription factors HNF-6 and OC-2. | 7.44e-07 | 5 | 10 | 2 | 19913497 | |
| Pubmed | Expression of a large family of POU-domain regulatory genes in mammalian brain development. | 1.12e-06 | 6 | 10 | 2 | 2739723 | |
| Pubmed | 1.12e-06 | 6 | 10 | 2 | 23867227 | ||
| Pubmed | 1.12e-06 | 6 | 10 | 2 | 12781686 | ||
| Pubmed | 1.12e-06 | 6 | 10 | 2 | 15381696 | ||
| Pubmed | 2.08e-06 | 8 | 10 | 2 | 23472758 | ||
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 8276396 | ||
| Pubmed | Isl1 and Pou4f2 form a complex to regulate target genes in developing retinal ganglion cells. | 2.68e-06 | 9 | 10 | 2 | 24643061 | |
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 27151576 | ||
| Pubmed | 3.34e-06 | 10 | 10 | 2 | 31231191 | ||
| Pubmed | Pou2f2 Regulates the Distribution of Dorsal Interneurons in the Mouse Developing Spinal Cord. | 4.09e-06 | 11 | 10 | 2 | 31787878 | |
| Pubmed | 5.79e-06 | 13 | 10 | 2 | 22115757 | ||
| Pubmed | 5.79e-06 | 13 | 10 | 2 | 22102297 | ||
| Pubmed | 6.76e-06 | 14 | 10 | 2 | 17936262 | ||
| Pubmed | 6.76e-06 | 14 | 10 | 2 | 16103213 | ||
| Pubmed | 6.76e-06 | 14 | 10 | 2 | 22534286 | ||
| Pubmed | 6.76e-06 | 14 | 10 | 2 | 23213462 | ||
| Pubmed | 7.80e-06 | 15 | 10 | 2 | 23830865 | ||
| Pubmed | Integral bHLH factor regulation of cell cycle exit and RGC differentiation. | 7.80e-06 | 15 | 10 | 2 | 29770538 | |
| Pubmed | 8.91e-06 | 16 | 10 | 2 | 19800948 | ||
| Pubmed | 8.91e-06 | 16 | 10 | 2 | 28603487 | ||
| Pubmed | A cis-regulatory module underlies retinal ganglion cell genesis and axonogenesis. | 1.01e-05 | 17 | 10 | 2 | 38823017 | |
| Pubmed | 1.01e-05 | 17 | 10 | 2 | 16472605 | ||
| Pubmed | 1.14e-05 | 18 | 10 | 2 | 31969659 | ||
| Pubmed | Stem cell competition driven by the Axin2-p53 axis controls brain size during murine development. | 1.14e-05 | 18 | 10 | 2 | 37054704 | |
| Pubmed | 1.27e-05 | 19 | 10 | 2 | 20627076 | ||
| Pubmed | Mammalian Llgl2 is necessary for proper branching morphogenesis during placental development. | 1.41e-05 | 20 | 10 | 2 | 21606200 | |
| Pubmed | 1.41e-05 | 20 | 10 | 2 | 17916349 | ||
| Pubmed | Onecut transcription factors act upstream of Isl1 to regulate spinal motoneuron diversification. | 1.56e-05 | 21 | 10 | 2 | 22833130 | |
| Pubmed | 1.71e-05 | 22 | 10 | 2 | 17400205 | ||
| Pubmed | Embryonic temporal-spatial delineation of excitatory spinal V3 interneuron diversity. | 1.71e-05 | 22 | 10 | 2 | 38160393 | |
| Pubmed | Lhx2 regulates the timing of β-catenin-dependent cortical neurogenesis. | 1.88e-05 | 23 | 10 | 2 | 26371318 | |
| Pubmed | 1.88e-05 | 23 | 10 | 2 | 19805515 | ||
| Pubmed | 2.22e-05 | 25 | 10 | 2 | 25775587 | ||
| Pubmed | 2.41e-05 | 26 | 10 | 2 | 28082864 | ||
| Pubmed | Onecut1 and Onecut2 play critical roles in the development of the mouse retina. | 2.60e-05 | 27 | 10 | 2 | 25313862 | |
| Pubmed | 2.80e-05 | 28 | 10 | 2 | 17698011 | ||
| Pubmed | 3.22e-05 | 30 | 10 | 2 | 30127719 | ||
| Pubmed | 3.22e-05 | 30 | 10 | 2 | 31399471 | ||
| Pubmed | 3.22e-05 | 30 | 10 | 2 | 29137925 | ||
| Pubmed | 3.44e-05 | 31 | 10 | 2 | 22711842 | ||
| Pubmed | c-Jun is required for the specification of joint cell fates. | 3.44e-05 | 31 | 10 | 2 | 23475960 | |
| Pubmed | 3.67e-05 | 32 | 10 | 2 | 25715394 | ||
| Pubmed | Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development. | 4.15e-05 | 34 | 10 | 2 | 23123965 | |
| Pubmed | 4.15e-05 | 34 | 10 | 2 | 26949938 | ||
| Pubmed | 4.40e-05 | 35 | 10 | 2 | 26988119 | ||
| Pubmed | Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors. | 4.66e-05 | 36 | 10 | 2 | 25715395 | |
| Pubmed | 5.20e-05 | 38 | 10 | 2 | 30201295 | ||
| Pubmed | 6.37e-05 | 42 | 10 | 2 | 30485816 | ||
| Pubmed | 7.65e-05 | 46 | 10 | 2 | 21102462 | ||
| Pubmed | A cascade of morphogenic signaling initiated by the meninges controls corpus callosum formation. | 9.05e-05 | 50 | 10 | 2 | 22365545 | |
| Pubmed | 9.05e-05 | 50 | 10 | 2 | 24449835 | ||
| Pubmed | 9.79e-05 | 52 | 10 | 2 | 28893950 | ||
| Pubmed | 1.44e-04 | 63 | 10 | 2 | 30916783 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 2.53e-04 | 1203 | 10 | 4 | 29180619 | |
| Pubmed | 2.68e-04 | 86 | 10 | 2 | 35103284 | ||
| Interaction | KDM5B interactions | 1.17e-07 | 100 | 10 | 4 | int:KDM5B | |
| Interaction | ONECUT2 interactions | 4.65e-06 | 7 | 10 | 2 | int:ONECUT2 | |
| Interaction | KRTAP6-1 interactions | 1.52e-05 | 103 | 10 | 3 | int:KRTAP6-1 | |
| Interaction | KRTAP9-2 interactions | 4.58e-05 | 149 | 10 | 3 | int:KRTAP9-2 | |
| Interaction | CYSRT1 interactions | 7.60e-05 | 511 | 10 | 4 | int:CYSRT1 | |
| Interaction | KRTAP1-1 interactions | 1.44e-04 | 219 | 10 | 3 | int:KRTAP1-1 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 7.92e-06 | 9 | 9 | 2 | 527 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 5.54e-05 | 23 | 9 | 2 | 523 | |
| Coexpression | DESCARTES_FETAL_EYE_HORIZONTAL_CELLS | 3.01e-05 | 22 | 10 | 2 | M40179 | |
| Coexpression | HU_FETAL_RETINA_HORIZONTAL | 1.01e-04 | 40 | 10 | 2 | M39265 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 1.12e-04 | 42 | 10 | 2 | M5895 | |
| Coexpression | DESCARTES_MAIN_FETAL_HORIZONTAL_CELLS | 1.40e-04 | 47 | 10 | 2 | M40096 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | 2.18e-04 | 328 | 10 | 3 | M39064 | |
| Coexpression | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN | 2.53e-04 | 63 | 10 | 2 | M10880 | |
| Coexpression | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN | 2.94e-04 | 68 | 10 | 2 | MM1036 | |
| Coexpression | BENPORATH_EED_TARGETS | 4.58e-04 | 1059 | 10 | 4 | M7617 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 5.57e-04 | 1115 | 10 | 4 | M10371 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 5.62e-04 | 94 | 10 | 2 | M2580 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 5.74e-04 | 95 | 10 | 2 | MM1328 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 6.61e-04 | 102 | 10 | 2 | M14455 | |
| Coexpression | DESCARTES_FETAL_LIVER_HEPATOBLASTS | 7.71e-04 | 505 | 10 | 3 | M40234 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 1.22e-03 | 591 | 10 | 3 | M2019 | |
| Coexpression | KRAS.PROSTATE_UP.V1_DN | 1.26e-03 | 141 | 10 | 2 | M2901 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 1.28e-03 | 601 | 10 | 3 | MM866 | |
| Coexpression | GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN | 1.33e-03 | 145 | 10 | 2 | M463 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 1.86e-04 | 769 | 9 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.31e-04 | 377 | 9 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 4.76e-04 | 390 | 9 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 4.83e-04 | 986 | 9 | 4 | PCBC_EB_fibroblast_1000 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 3.48e-06 | 140 | 10 | 3 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-06 | 195 | 10 | 3 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.70e-06 | 197 | 10 | 3 | c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-05 | 200 | 10 | 3 | fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-7|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.22e-04 | 101 | 10 | 2 | 385e67efc555e3543ddb02cda7edd88babb83b42 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.75e-04 | 148 | 10 | 2 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.75e-04 | 148 | 10 | 2 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.95e-04 | 151 | 10 | 2 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 151 | 10 | 2 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-04 | 160 | 10 | 2 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 163 | 10 | 2 | 1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 163 | 10 | 2 | 03d9fa615d9d02ef98e20f28a10aaa6894dd4960 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-04 | 165 | 10 | 2 | 361a605d8f833d9ec54b120480dce397da35f9c3 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-04 | 166 | 10 | 2 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.04e-04 | 167 | 10 | 2 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.04e-04 | 167 | 10 | 2 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.12e-04 | 168 | 10 | 2 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.19e-04 | 169 | 10 | 2 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-04 | 173 | 10 | 2 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 6.56e-04 | 174 | 10 | 2 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.56e-04 | 174 | 10 | 2 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.63e-04 | 175 | 10 | 2 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 175 | 10 | 2 | 78b453e220218c84557f244ef7a760e4a1952761 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 175 | 10 | 2 | c1a8a55af825d5913095f919fa860828df9c273e | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.63e-04 | 175 | 10 | 2 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.63e-04 | 175 | 10 | 2 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | Entopeduncular-Endothelial-MURAL|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.71e-04 | 176 | 10 | 2 | b8e52bec78876562a25f0b0de502aa9372b28bd2 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.71e-04 | 176 | 10 | 2 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.71e-04 | 176 | 10 | 2 | 10c1f31c27e54b70f58f0b0086ac74dee2ce4197 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 176 | 10 | 2 | 5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-04 | 177 | 10 | 2 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-04 | 177 | 10 | 2 | 35d42b07d9c31528bf59199e361bb8a3bfbe3b75 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-04 | 178 | 10 | 2 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.94e-04 | 179 | 10 | 2 | 99167ac678cae5c35b1d4f4a81b32000437c00c2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 179 | 10 | 2 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | Striatum-Endothelial-MURAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.94e-04 | 179 | 10 | 2 | 3d58babf44e47462c3d4129dd2e94a2339fd7ce0 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-04 | 181 | 10 | 2 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-04 | 181 | 10 | 2 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-04 | 181 | 10 | 2 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | Cerebellum-Endothelial-MURAL|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.17e-04 | 182 | 10 | 2 | b2f03f61aebb5920595fed8b9d6799a09353419b | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.17e-04 | 182 | 10 | 2 | da61e7cb2537c567968d8bd8baf537ecdff0ab18 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-04 | 183 | 10 | 2 | 1701c8c212f1fdb6e4764375542a203e19753d14 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | droplet-Heart-nan-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-04 | 185 | 10 | 2 | c61267cfadea018794f7964904445787629a40d1 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-04 | 185 | 10 | 2 | 3a592719d5643011954f89d5bb61a5e94682b68e | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.48e-04 | 186 | 10 | 2 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.73e-04 | 189 | 10 | 2 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.89e-04 | 191 | 10 | 2 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-04 | 193 | 10 | 2 | 4f4f430d7e1b65e19ca829f55ca93edeb6c1c85d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-04 | 193 | 10 | 2 | 47d189bac0ef4df2f5c6dd987e46aca85bd7e2af | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.14e-04 | 194 | 10 | 2 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.30e-04 | 196 | 10 | 2 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-04 | 196 | 10 | 2 | 9afd0a7135028a446f06bb68f334e79b8f171b45 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-04 | 196 | 10 | 2 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-04 | 196 | 10 | 2 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-04 | 196 | 10 | 2 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.39e-04 | 197 | 10 | 2 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.39e-04 | 197 | 10 | 2 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.39e-04 | 197 | 10 | 2 | 2d92b0483d57541aee382dda80e42cf66e813d6b | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.39e-04 | 197 | 10 | 2 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.47e-04 | 198 | 10 | 2 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 8.56e-04 | 199 | 10 | 2 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.56e-04 | 199 | 10 | 2 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.56e-04 | 199 | 10 | 2 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.64e-04 | 200 | 10 | 2 | b5019b9d48f32cffd4645a5c0f3e0ac504ea8019 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.64e-04 | 200 | 10 | 2 | 345f1eac498cc87fd7bf08e7312608b2d6fe1dd7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.64e-04 | 200 | 10 | 2 | 8f5d98f962ddd8c4658c89ff8a2894de1228562a | |
| Drug | NSC123116 | 9.53e-06 | 11 | 10 | 2 | CID000275966 | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 7.32e-05 | 197 | 10 | 3 | 4403_UP | |
| Drug | Procarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 7.43e-05 | 198 | 10 | 3 | 3533_UP | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 7.43e-05 | 198 | 10 | 3 | 3583_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 7.66e-05 | 200 | 10 | 3 | 3714_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 7.66e-05 | 200 | 10 | 3 | 6095_UP | |
| Drug | calcium hydroxide | 1.09e-04 | 36 | 10 | 2 | CID000014777 | |
| Drug | O-EC | 4.86e-04 | 76 | 10 | 2 | CID006338557 | |
| Drug | 3-(phosphonomethyl)pyridine-2-carboxylic acid | 5.52e-04 | 81 | 10 | 2 | CID000001629 | |
| Drug | MPC-1304 | 6.37e-04 | 87 | 10 | 2 | CID000002225 | |
| Drug | AC1L1AGT | 1.03e-03 | 111 | 10 | 2 | CID000000982 | |
| Drug | CT-26 | 1.61e-03 | 139 | 10 | 2 | CID003034916 | |
| Drug | panobinostat | 1.85e-03 | 1333 | 10 | 4 | ctd:C496932 | |
| Drug | histidinate | 2.51e-03 | 174 | 10 | 2 | CID000000773 | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.54e-03 | 175 | 10 | 2 | 4726_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; PC3; HT_HG-U133A | 2.74e-03 | 182 | 10 | 2 | 6663_UP | |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 2300_UP | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 1211_UP | |
| Drug | Niclosamide | 3.01e-03 | 191 | 10 | 2 | ctd:D009534 | |
| Drug | Orlistat; Up 200; 10uM; PC3; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 6388_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 3375_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 2748_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 5291_DN | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 2899_UP | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 4174_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 2621_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 5342_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6741_UP | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6727_UP | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 4192_DN | |
| Drug | Trichlormethiazide [133-67-5]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4198_DN | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4358_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 2653_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5813_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5261_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4300_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5240_UP | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 3.14e-03 | 195 | 10 | 2 | 268_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3266_UP | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4373_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 2761_DN | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3298_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4345_DN | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 2538_UP | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4181_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3829_UP | |
| Drug | Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4263_UP | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 6834_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 10uM; MCF7; HG-U133A | 3.14e-03 | 195 | 10 | 2 | 405_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4288_UP | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4200_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; HL60; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2735_UP | |
| Drug | DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2877_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4281_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3690_UP | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2322_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5279_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3820_UP | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; HL60; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2724_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4093_UP | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2277_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4324_UP | |
| Drug | daunorubicin HCl; Up 200; 1uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 7511_UP | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3766_DN | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5985_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3706_UP | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 6396_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4766_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5757_UP | |
| Drug | prednisolone; Down 200; 1uM; MCF7; HG-U133A | 3.17e-03 | 196 | 10 | 2 | 265_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4381_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4644_UP | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4335_UP | |
| Drug | Estriol [50-27-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3563_UP | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5251_UP | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5331_UP | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4151_DN | |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4793_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5947_DN | |
| Drug | staurosporine; Down 200; 0.01uM; MCF7; HG-U133A | 3.17e-03 | 196 | 10 | 2 | 425_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 6273_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4204_DN | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 1828_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 6629_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 6666_UP | |
| Disease | lower face morphology measurement | 5.97e-04 | 109 | 10 | 2 | EFO_0010948 | |
| Disease | age at menarche | 8.76e-04 | 594 | 10 | 3 | EFO_0004703 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.23e-03 | 157 | 10 | 2 | DOID:224 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APHAHHPLHKGDHHH | 66 | Q3C1V8 | |
| NHHHHHHHALHEAPK | 331 | A6QL63 | |
| TKHVHHHYIHHHAVP | 511 | Q9Y2T1 | |
| SSMAHHHHPLHPHHW | 171 | Q9UBP5 | |
| HGSRDHHHPHKPHEH | 281 | P04196 | |
| PHKHHSHEQHPHGHH | 351 | P04196 | |
| STVSDKFPHHHHHHH | 116 | Q9UBC0 | |
| STVSDKFHHPHPHHH | 161 | O95948 | |
| PPKKEHHHHHHHSES | 361 | P51608 | |
| HHHHHHHSESPKAPV | 366 | P51608 | |
| SQSKSHHHHPPHHSP | 121 | Q12837 | |
| RDAHDEPHHADHHPH | 216 | P20265 | |
| HMHDVYMRHHHPHAH | 221 | A8MV65 |